Natera (NTRA) Competitors $140.12 +3.55 (+2.60%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$141.25 +1.13 (+0.81%) As of 08/5/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NTRA vs. FMS, HIMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, and WGSShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and GeneDx (WGS). These companies are all part of the "healthcare" industry. Natera vs. Its Competitors Fresenius Medical Care AG & Co. KGaA Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent GeneDx Natera (NASDAQ:NTRA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability. Is NTRA or FMS more profitable? Fresenius Medical Care AG & Co. KGaA has a net margin of 3.18% compared to Natera's net margin of -10.36%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.25% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-10.36% -18.29% -11.68% Fresenius Medical Care AG & Co. KGaA 3.18%6.25%2.88% Which has better valuation and earnings, NTRA or FMS? Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B11.28-$190.43M-$1.47-95.32Fresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.1221.78 Do analysts prefer NTRA or FMS? Natera presently has a consensus price target of $183.76, indicating a potential upside of 31.15%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $27.80, indicating a potential upside of 13.98%. Given Natera's stronger consensus rating and higher probable upside, analysts plainly believe Natera is more favorable than Fresenius Medical Care AG & Co. KGaA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 1 Strong Buy rating(s) 3.06Fresenius Medical Care AG & Co. KGaA 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to NTRA or FMS? In the previous week, Natera had 27 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 30 mentions for Natera and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 0.82 beat Fresenius Medical Care AG & Co. KGaA's score of 0.80 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 17 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, NTRA or FMS? Natera has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Do institutionals & insiders have more ownership in NTRA or FMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 7.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryNatera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.65B$7.17B$5.59B$9.53BDividend YieldN/A2.87%4.73%4.14%P/E Ratio-95.3265.8528.9123.88Price / Sales11.2830.36445.9598.82Price / CashN/A26.2535.6858.35Price / Book15.488.758.165.60Net Income-$190.43M$239.96M$3.25B$265.26M7 Day Performance-0.60%-0.54%1.16%-0.14%1 Month Performance-13.24%-2.31%8.26%6.08%1 Year Performance38.84%24.58%29.19%24.22% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera3.5836 of 5 stars$140.12+2.6%$183.76+31.1%+43.1%$18.65B$1.70B-95.324,434Upcoming EarningsInsider TradeFMSFresenius Medical Care AG & Co. KGaA3.7046 of 5 stars$25.86-2.2%$27.80+7.5%+29.9%$15.18B$19.49B23.091,384News CoverageHIMSHims & Hers Health2.5522 of 5 stars$58.67+1.8%$39.83-32.1%+211.2%$13.13B$1.48B85.031,637Trending NewsEarnings ReportAnalyst ForecastGap DownGHGuardant Health3.4925 of 5 stars$44.27-0.3%$54.45+23.0%+51.1%$5.48B$739.02M-13.062,021Earnings ReportOPCHOption Care Health4.6195 of 5 stars$29.77+0.3%$35.50+19.2%-5.4%$4.87B$5.00B24.018,088News CoverageEarnings ReportAnalyst RevisionRDNTRadNet4.0783 of 5 stars$57.83+0.7%$69.60+20.4%+0.3%$4.34B$1.83B-134.4911,021Positive NewsUpcoming EarningsBTSGBrightSpring Health Services2.9365 of 5 stars$20.48-0.2%$24.90+21.6%+77.7%$3.60B$11.27B73.1435,000Earnings ReportSHCSotera Health1.8909 of 5 stars$12.29-0.1%$16.00+30.2%-21.3%$3.49B$1.10B153.643,000SGRYSurgery Partners2.7699 of 5 stars$22.44+5.6%$33.33+48.5%-22.9%$2.88B$3.17B-14.6715,000News CoveragePositive NewsGap UpCONConcentra Group Holdings Parent2.8762 of 5 stars$20.05+2.0%$28.50+42.1%-11.0%$2.57B$1.93B14.9611,250Upcoming EarningsWGSGeneDx3.0473 of 5 stars$84.91+6.4%$92.33+8.7%+278.4%$2.42B$305.45M-60.221,200Earnings ReportAnalyst Upgrade Related Companies and Tools Related Companies FMS Competitors HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors CON Competitors WGS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRA) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.